Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANNABIS SATIVA SUBSP. INDICA TOP vs CANTHARIDIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANNABIS SATIVA SUBSP. INDICA TOP vs CANTHARIDIN: Safety Overview

Metric CANNABIS SATIVA SUBSP. INDICA TOP CANTHARIDIN
Total FAERS Reports 8,646 114
Deaths Reported 3,040 0
Death Rate 35.2% N/A
Hospitalizations 2,907 3
Average Patient Age 33.8 yrs 17.6 yrs
% Female Patients 31.7% 53.3%
FDA Approval Date N/A Jul 21, 2023
Manufacturer N/A Verrica Pharmaceuticals Inc.
Route N/A TOPICAL
Marketing Status N/A Prescription